1. Backes, M, Cannabis Pharmacy,  New York, New York.  Black Dog & Leventhal Publishers; 2017.

  2. E.B. Russo, (2011), “Taming THC: Potential Cannabis Synergy and Phytocannabinoid- Terpenoid Entourage Effects, “British Journal of Pharmacology, 163(7), 1344-1364.  Doi: 10.1111/j.1476-5381.2011/j.1476-5381.2011.01238.x.  

  3. Englund A, Morrison P, Nottage, J, et al. Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment. AMA Manual of Style Guide (10th). October 5, 2012;27(1): 19-27.  

  4. H. Curran, Valerie, et al., “Keep off the Grass?  Cannabis, Cognition and Addiction,” Nature Reviews Neuroscience 17.5 (2016): 293-306.

  5. Johnson JR, Potts R. Cannabis-based medicines in the treatment of cancer pain: a randomised, double-blind, parallel group, placebo controlled, comparative study of the efficacy, safety and tolerability of Sativex and Tetranabinex in patients with cancer-related pain. Edinburgh, Scotland: 2005. Mar, 8–11.

  6. Russo EB. The Case for the Entourage Effect and Conventional Breeding of Clinical Cannabis: No "Strain," No Gain. Front Plant Sci. 2019;9:1969. Published 2019 Jan 9. doi:10.3389/fpls.2018.01969

  7. Russo EB, Guy GW, Robson PJ. Cannabis, pain and sleep: lessons from therapeutic clinical trials of Sativex® cannabis based medicine. Chem Biodivers. 2007a;4:1729–43.